MedtechWomen Announces Third Annual Conference by and for Women in Medical Technology

MedtechVision 2013 Will Focus on How to Create Value in Medtech Today

for MedtechWomenNicole Osmer, 650-454-0504

MedtechWomen today announced that registration is open for MedtechVision 2013, the third annual conference designed by and for women on the forefront of medical innovation. The conference will be held September 10, 2013, at the Rosewood Sand Hill in Menlo Park, Calif. A discount of $200 is available for conference attendees who register on or before Thursday, August 1.

The conference will host more than 25 distinguished panelists and speakers, including business leaders, inventors, investors, physicians and policymakers. The event will feature keynotes from Sue Siegel, CEO, healthymagination, GE, and Kelly Corrigan, bestselling author and cancer survivor.

“The theme of this year’s conference – value – centers around the concept of providing better care to more with less,” said Amy Belt, co-founder of MedtechWomen and director of Covidien Ventures. “It is clear that the medtech industry needs to innovate to meet this challenge. At this year’s conference, we’ll explore several ways to accomplish this: driving value from within, innovating for value, funding value stories, adding new services that amplify the value of the medical technology and answering the unique demands of emerging markets. This year’s set of experts will lead us through these areas and share what they’ve learned and what we can adopt to meet the challenge of driving value in today’s healthcare environment.”

“Any definition of value involves relative differences between product benefits and cost and customers’ perception of those—so to truly explore value requires that we again have multiple stakeholder voices at MedtechVision 2013,” said Deborah Kilpatrick, Ph.D., MedtechWomen co-founder and chief commercial officer of CardioDx. “The conference has set a precedent for highlighting the spectrum of voices involved in health care delivery, and this year will follow suit to ensure we fully address this intriguing topic.”

Panel topics include:

Conference panelists include executives from Covidien, Abbott, Medtronic, Edwards Lifesciences, OmniGuide, Acclarent, Intersect ENT, Versant Ventures, New Leaf Ventures, Oxford Finance, Psilos Group, iRythm Technologies, Asthmopolis, Auxogyn, R&D Systems China, Core Diagnostics, Ernst & Young LLP, Kilpatrick Townsend & Stockton and D-Rev.

The lead sponsor for the conference is Covidien, a leading global healthcare products company. Additional sponsors include Edwards Lifesciences, Fish & Richardson, Essex Woodlands, KFA Search, BioQuest, Exponent, Silicon Valley Bank and LehmanMillet.

To register for the conference please visit .

MedtechWomen is a group of women who came together with a vision to highlight and connect women leaders in medical devices and diagnostics. In 2010, they decided to act on their vision of bringing together sector leaders and policymakers to discuss real-world solutions to the most challenging issues facing our industry today. They enlisted the support of their mentors and a broadening circle of colleagues to bring this vision to reality, resulting in the inaugural MedtechVision conference in 2011.

Founders and organizing members of MedtechWomen are innovators from across the U.S. in varied aspects of the medtech sector including business leaders, financial investors, researchers, physicians and experts in new product commercialization.

For more information please visit .

Suggested Articles

Genealogy company Ancestry is expanding into genetic health testing, ramping up competition with 23andMe.

Most healthcare organizations are lagging in awareness and preparedness for compliance with proposed interoperability rules, according to a survey.

Medical Group Management Association officials got out their crystal ball Monday.